Lê, Minh P <br/><br/>
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.  [electronic resource] 

 -  Antiviral therapy  2015 
 - 507-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2040-2058 
<br/><br/><label>Standard No.: </label>10.3851/IMP2936  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Atazanavir Sulfate--adverse effects<br/>CD4 Lymphocyte Count<br/>Cross-Sectional Studies<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Female<br/>HIV Protease Inhibitors--adverse effects<br/>HIV-1--drug effects<br/>Humans<br/>Hyperbilirubinemia--chemically induced<br/>Infant, Newborn<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Ritonavir--adverse effects<br/>Viral Load--drug effects